Table I. Patient Characteristics.
Characteristic | Total (n = 30) |
---|---|
Median age, range (years) | 72, 55 – 86 |
Zubrod Performance Status | |
0 | 16 |
1 | 13 |
2 | 1 |
Median pre-treatment PSA, range (ng/ml) | 73, 7 – 11,420 |
Median hemoglobin, range (g/dL) | 12.8, 9.7 – 15.5 |
Median alkaline phosphatase, range (U/L) | 96, 36 – 271 |
Median creatinine, range (mg/dL) | 0.87, 0.60 – 1.83 |
Prior therapy (# patients) | |
LHRH antagonist | 30 |
AR antagonist | 30 |
Docetaxel | 30 |
Cabazitaxel | 1 |
Vinorelbine | 1 |
Abiraterone | 4 |
Orteronel | 2 |
Enzalutamide | 1 |
Sipuleucel-T | 4 |
Atrasentan | 1 |
Silutuximab | 1 |
Cabozantanib | 1 |